BBC icon

Virtus LifeSci Biotech Clinical Trials ETF

13 hedge funds and large institutions have $3.08M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$351K
2 +$2.71K
3 +$1.23K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.29M
2
$968K
3
$368K
4
$358K
5
$27.9K
6
$23.4K
7
$22K
8
$12.5K
9
$6.48K
10
$2.79K
11
$1.23K
12
$280
13
$140
14
15